People · Operator

Rey Banatao

Named in public records as an officer, director or promoter · active 2013–2018 · Healthtech, Other

2
Companies
2
Filings
$26.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Medical Creations, Inc.HealthtechSeries A$17.9M$122.5M2018
Morphlabs, Inc.OtherSeries A$8.4M$127.9M2013
Operator network

Rey Banatao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Robert Nelsen · 22 companies · 1 sharedRobert NelsenRichard Klausner · 7 companies · 1 sharedRichard KlausnerScott Ward · 7 companies · 1 sharedScott WardRobert Kerrey · 2 companies · 1 sharedRobert KerreyAmy Hill · 1 companies · 1 sharedAmy HillMaynard Carkhuff · 1 companies · 1 sharedMaynard CarkhuffMiguelangel Sosa · 1 companies · 1 sharedMiguelangel SosaNick Pliam · 1 companies · 1 sharedNick PliamDado Banatao · 5 companies · 1 sharedDado BanataoWinston Damarillo · 3 companies · 1 sharedWinston DamarilloKevin Belmonte · 1 companies · 1 sharedKevin BelmonteMartin Bautista · 1 companies · 1 sharedMartin BautistaMike Gleason · 1 companies · 1 sharedMike GleasonVictor Alvarez · 1 companies · 1 sharedVictor AlvarezMedical Creations, Inc. · $17.9M raisedMedical Creations, In…Morphlabs, Inc. · $8.4M raisedMorphlabs, Inc.Rey BanataoRB
Rey Banatao Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Rey Banatao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Robert Nelsen122
Richard Klausner17
Scott Ward17
Dado Banatao15
Winston Damarillo13
Robert Kerrey12
Kevin Belmonte11
Martin Bautista11
Mike Gleason11
Maynard Carkhuff11
Nick Pliam11
Miguelangel Sosa11
Amy Hill11
Victor Alvarez11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.